MedKoo Biosciences, Inc.
About MedKoo Products
Careers at MedKoo
Remove your patented product from our web
Browse all products
Browse products by research area
Newest stocked products
Frequently asked questions
Process Research & Development
Antibody Drug Conjugation
Hapten Design and Synthesis
How To Order
Terms and Conditions
Download MedKoo Catalogues
Amino Acid Nomenclature Guide
Useful Free Databases
NMR Chemical Shifts of Impurities Charts
MedKoo Chemical Nomenclature
Elemental Period Table
or product name starting with:
WIN 51,708 is a neurokinin-1 receptor antagonist.
WIN54954 is a broad-spectrum antipicornavirus drug. WIN 54 954 is a potent antivir...
WIN 55212-2 mesylate
WIN 55212-2 is a CB1 agonist (cannabinoid receptor agonist). WIN 55212-2 impairs c...
(−)-WIN 55,212-3 mesylate
(−)-WIN 55,212-3 mesylate is an aminoalkylindole derivative which acts as a compet...
WIN 62,577 is a mAChR allosteric antagonist.
WIN 64338 hydrochloride
WIN 64338 hydrochloride is a potent, non-peptide, competitive bradykinin B2 recept...
Win 64821 is a dimerized Trp-Phe condensate; a nonpeptide neurokinin antagonist; s...
WIN 66306 is a cyclic heptapeptide antagonist of neurokinin-1 (NK1) and NK2 recept...
WIN-67722 is a water-soluble ester of diatrizoic acid that is approximately 50% io...
WIN-68056 is a wetting agent in x-ray contrast compositions.
Windorphen is a cell-permeable bis(4-methoxyphenyl)chloroacrylaldehyde whose (Z)-i...
Wiskostatin is a cell-permeable, selective inhibitor of neural WASP (N-WASP). It d...
Withaferin A is a steroidal lactone, derived from Acnistus arborescens,Withania so...
Withangulatin A is a natural potent antitumor agent, targeting sarco/endoplasmic r...
Withanolide B is a withanolide that has been found in W. somnifera. Unlike withano...
Withanone combined with Cucurbitacin B has selective toxicity to cancer cells.
Witisol is a sunscreen agent linked with contact dermatitis.
WJ35435 is a dual inhibitor of histone deacetylase and topoisomerase I.
WJ460 is an inhibitor of myoferlin (MYOF) which exerts anti-metastatic activity in...
WJD008 is a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamyci...
WJM-921 is a PfATP4 inhibitor with EC50= 8 nM. WJM-921 demonstrates oral efficacy ...
WK1 is the niacin derivative of AMD070 as potent CXCR4 antagonist, demonstrating s...
WK-298 is a potent inhibitor of the MDM2/MDMX-p53 interaction.
WK-30 is a bioactive chemical.
WK500B is a BCL6 inhibitor. WK500B engaged BCL6 inside cells, blocked BCL6 repress...
WK-X-34 is inhibitor of P-glycoprotein and Breast Cancer Resistance Protein (BCRP).
WKYMVm is a synthetic peptide agonist of formyl peptide receptor 1 (FPR1) and FPR2...
WL12 is the first inhibitor of JMJD6 enzymatic activity and JMJD6-dependent cell p...
WL 19 is an angiotensin II type 2 receptor antagonist.
WM-1119 is a highly potent, selective inhibitor of lysine acetyltransferase KAT6A ...
WM-382 is a PMX inhibitor with antimalarial activity. Oral administration of WM382...
WM 3835 is a lysine acetyltransferase HBO1 (KAT7) inhibitor. It reduces H3K14ac le...
WM-586 is a biochemical inhibiting WDR5-MYC interaction, specifically targeting th...
WM-8014, also known as MOZ-IN-3, is a highly potent inhibitor of KAT6A (IC50 = 0.0...
WMS-1410 is a novel GluN2B-specific NMDAR antagonist, completely preventing the de...
WMS-2539 is a potent uncompetitive NMDA receptor antagonist.
WN1316 is a unique neuroprotectant against oxidative injury, being a highly promis...
WNK1-IN-1 is a WNK1 inhibitor.
WNK463, also known as NVP-WNK463, is a potent and orally bioavailable pan-WNK-kina...
WNK-IN-11 is a potent, selective and orally active inhibitor of WNK1 kinase.
WNK-IN-12 is a potent, selective and orally active inhibitor of WNK1 kinase.
WNK-IN-3 is a novel allosteric WNK kinase inhibitor.
WNK-IN-7 is a potent and selectiive inhibitor of WNK1 kinase.
WNK-IN-B, also known as Compound B, is a Wnk signalling inhibitor. WNK-IN-B is a c...
WNN-01125 is a novel fluorescent highly potent agonist at the adenosine A3 recepto...
Wnt-C59 is a potent porcupine (PORCN) inhibitor. Wnt-C59 inhibits PORCN activity i...
WNY0824 is a BRD4 and PLK1 inhibitor.
WNY1613 is a PI3K inhibitor.
WO-459 is a novel GPR52 agonist, dose-dependently inducing elevation of intracellu...
WOBE437 is a selective endocannabinoid reuptake inhibitor which reduces disease pr...